Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 May;70(5):2852–2860. doi: 10.1128/jvi.70.5.2852-2860.1996

Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.

M E Waris 1, C Tsou 1, D D Erdman 1, S R Zaki 1, L J Anderson 1
PMCID: PMC190142  PMID: 8627759

Abstract

Vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV) caused excessive disease in infants upon subsequent natural infection with RSV. Recent studies with BALB/c mice have suggested that T cells are important contributors to lung immunopathology during RSV infection. In this study, we investigated vaccine-induced enhanced disease by immunizing BALB/c mice with live RSV intranasally or with FI-RSV intramuscularly. The mice were challenged with RSV 6 weeks later, and the pulmonary inflammatory response was studied by analyzing cells obtained by bronchoalveolar lavage 4 and 8 days after challenge. FI-RSV-immunized mice had an increased number of total cells, granulocytes, eosinophils, and CD4+ cells but a decreased number of CD8+ cells. The immunized mice also had a marked increase in the expression of mRNA for the Th2-type cytokines interleukin-5 (IL-5) and IL-13 as well as some increase in the expression of IL-10 (a Th2-type cytokine) mRNA and some decrease in the expression of IL-12 (a Th1-type cytokine) mRNA. The clear difference in the pulmonary inflammatory response to RSV between FI-RSV- and live-RSV-immunized mice suggests that this model can be used to evaluate the disease-enhancing potential of candidate RSV vaccines and better understand enhanced disease.

Full Text

The Full Text of this article is available as a PDF (270.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alwan W. H., Kozlowska W. J., Openshaw P. J. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med. 1994 Jan 1;179(1):81–89. doi: 10.1084/jem.179.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson L. J., Hierholzer J. C., Bingham P. G., Stone Y. O. Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol. 1985 Dec;22(6):1050–1052. doi: 10.1128/jcm.22.6.1050-1052.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson L. J., Tsou C., Potter C., Keyserling H. L., Smith T. F., Ananaba G., Bangham C. R. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis. 1994 Nov;170(5):1201–1208. doi: 10.1093/infdis/170.5.1201. [DOI] [PubMed] [Google Scholar]
  4. Brown K. D., Zurawski S. M., Mosmann T. R., Zurawski G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol. 1989 Jan 15;142(2):679–687. [PubMed] [Google Scholar]
  5. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969 Apr;89(4):449–463. doi: 10.1093/oxfordjournals.aje.a120957. [DOI] [PubMed] [Google Scholar]
  6. Connors M., Giese N. A., Kulkarni A. B., Firestone C. Y., Morse H. C., 3rd, Murphy B. R. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J Virol. 1994 Aug;68(8):5321–5325. doi: 10.1128/jvi.68.8.5321-5325.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Connors M., Kulkarni A. B., Firestone C. Y., Holmes K. L., Morse H. C., 3rd, Sotnikov A. V., Murphy B. R. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol. 1992 Dec;66(12):7444–7451. doi: 10.1128/jvi.66.12.7444-7451.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dubucquoi S., Desreumaux P., Janin A., Klein O., Goldman M., Tavernier J., Capron A., Capron M. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med. 1994 Feb 1;179(2):703–708. doi: 10.1084/jem.179.2.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edwards K. M., Dupont W. D., Westrich M. K., Plummer W. D., Jr, Palmer P. S., Wright P. F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994 Jan;169(1):68–76. doi: 10.1093/infdis/169.1.68. [DOI] [PubMed] [Google Scholar]
  10. Erdman D. D., Anderson L. J. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus. J Clin Microbiol. 1990 Dec;28(12):2744–2749. doi: 10.1128/jcm.28.12.2744-2749.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fernie B. F., Gerin J. L. The stabilization and purification of respiratory syncytial virus using MgSO4. Virology. 1980 Oct 15;106(1):141–144. doi: 10.1016/0042-6822(80)90229-9. [DOI] [PubMed] [Google Scholar]
  12. Fulginiti V. A., Eller J. J., Sieber O. F., Joyner J. W., Minamitani M., Meiklejohn G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969 Apr;89(4):435–448. doi: 10.1093/oxfordjournals.aje.a120956. [DOI] [PubMed] [Google Scholar]
  13. Graham B. S., Henderson G. S., Tang Y. W., Lu X., Neuzil K. M., Colley D. G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol. 1993 Aug 15;151(4):2032–2040. [PubMed] [Google Scholar]
  14. Graham B. S., Perkins M. D., Wright P. F., Karzon D. T. Primary respiratory syncytial virus infection in mice. J Med Virol. 1988 Oct;26(2):153–162. doi: 10.1002/jmv.1890260207. [DOI] [PubMed] [Google Scholar]
  15. Gruber W. C., Taber L. H., Glezen W. P., Clover R. D., Abell T. D., Demmler R. W., Couch R. B. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child. 1990 May;144(5):595–600. doi: 10.1001/archpedi.1990.02150290089035. [DOI] [PubMed] [Google Scholar]
  16. Hayes P. J., Scott R., Wheeler J. In vivo production of tumour necrosis factor-alpha and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virus. J Med Virol. 1994 Apr;42(4):323–329. doi: 10.1002/jmv.1890420402. [DOI] [PubMed] [Google Scholar]
  17. Hildreth S. W., Baggs R. R., Brownstein D. G., Castleman W. L., Paradiso P. R. Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3-6 months after immunization. Vaccine. 1993;11(6):615–618. doi: 10.1016/0264-410x(93)90304-g. [DOI] [PubMed] [Google Scholar]
  18. Kapikian A. Z., Mitchell R. H., Chanock R. M., Shvedoff R. A., Stewart C. E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969 Apr;89(4):405–421. doi: 10.1093/oxfordjournals.aje.a120954. [DOI] [PubMed] [Google Scholar]
  19. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  20. Kim J. M., Brannan C. I., Copeland N. G., Jenkins N. A., Khan T. A., Moore K. W. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol. 1992 Jun 1;148(11):3618–3623. [PubMed] [Google Scholar]
  21. Kimpen J. L., Rich G. A., Mohar C. K., Ogra P. L. Mucosal T cell distribution during infection with respiratory syncytial virus. J Med Virol. 1992 Mar;36(3):172–179. doi: 10.1002/jmv.1890360305. [DOI] [PubMed] [Google Scholar]
  22. Montgomery R. A., Dallman M. J. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol. 1991 Jul 15;147(2):554–560. [PubMed] [Google Scholar]
  23. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  24. Murphy B. R., Sotnikov A. V., Lawrence L. A., Banks S. M., Prince G. A. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine. 1990 Oct;8(5):497–502. doi: 10.1016/0264-410x(90)90253-i. [DOI] [PubMed] [Google Scholar]
  25. Oliveira D. A., Holloway B. P., Durigon E. L., Collins W. E., Lal A. A. Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg. 1995 Feb;52(2):139–144. doi: 10.4269/ajtmh.1995.52.139. [DOI] [PubMed] [Google Scholar]
  26. Openshaw P. J., Clarke S. L., Record F. M. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int Immunol. 1992 Apr;4(4):493–500. doi: 10.1093/intimm/4.4.493. [DOI] [PubMed] [Google Scholar]
  27. Openshaw P. J. Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus. Clin Exp Immunol. 1989 Feb;75(2):324–328. [PMC free article] [PubMed] [Google Scholar]
  28. Openshaw P. J. Pulmonary epithelial T cells induced by viral infection express T cell receptors alpha/beta. Eur J Immunol. 1991 Mar;21(3):803–806. doi: 10.1002/eji.1830210338. [DOI] [PubMed] [Google Scholar]
  29. Paul W. E., Seder R. A. Lymphocyte responses and cytokines. Cell. 1994 Jan 28;76(2):241–251. doi: 10.1016/0092-8674(94)90332-8. [DOI] [PubMed] [Google Scholar]
  30. Piedra P. A., Wyde P. R., Castleman W. L., Ambrose M. W., Jewell A. M., Speelman D. J., Hildreth S. W. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine. 1993 Nov;11(14):1415–1423. doi: 10.1016/0264-410x(93)90170-3. [DOI] [PubMed] [Google Scholar]
  31. Prince G. A., Jenson A. B., Hemming V. G., Murphy B. R., Walsh E. E., Horswood R. L., Chanock R. M. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol. 1986 Mar;57(3):721–728. doi: 10.1128/jvi.57.3.721-728.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schoenhaut D. S., Chua A. O., Wolitzky A. G., Quinn P. M., Dwyer C. M., McComas W., Familletti P. C., Gately M. K., Gubler U. Cloning and expression of murine IL-12. J Immunol. 1992 Jun 1;148(11):3433–3440. [PubMed] [Google Scholar]
  33. Sparrevohn S., Wulff H. R. The nuclear segmentation of eosinophils under normal and pathological conditions. Acta Haematol. 1967;37(2):120–125. doi: 10.1159/000209059. [DOI] [PubMed] [Google Scholar]
  34. Tang Y. W., Graham B. S. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest. 1994 Nov;94(5):1953–1958. doi: 10.1172/JCI117546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tang Y. W., Graham B. S. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. J Infect Dis. 1995 Sep;172(3):734–738. doi: 10.1093/infdis/172.3.734. [DOI] [PubMed] [Google Scholar]
  36. Taylor G., Stott E. J., Hughes M., Collins A. P. Respiratory syncytial virus infection in mice. Infect Immun. 1984 Feb;43(2):649–655. doi: 10.1128/iai.43.2.649-655.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 1994 Dec 15;84(12):4008–4027. [PubMed] [Google Scholar]
  38. Vaux-Peretz F., Chapsal J. M., Meignier B. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice. Vaccine. 1992;10(2):113–118. doi: 10.1016/0264-410x(92)90027-h. [DOI] [PubMed] [Google Scholar]
  39. Waris M., Meurman O., Mufson M. A., Ruuskanen O., Halonen P. Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virus. J Med Virol. 1992 Oct;38(2):111–116. doi: 10.1002/jmv.1890380208. [DOI] [PubMed] [Google Scholar]
  40. Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med. 1988 Jan 1;167(1):43–56. doi: 10.1084/jem.167.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES